Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria.
Transpl Int. 2010 Nov;23(11):1071-81. doi: 10.1111/j.1432-2277.2010.01158.x. Epub 2010 Aug 31.
Heme oxygenase-1 (HO-1) is the rate-limiting enzyme in heme catabolism that converts heme to Fe++, carbon monoxide and biliverdin. HO-1 acts anti-inflammatory and modulates apoptosis in many pathological conditions. In transplantation, HO-1 is overexpressed in organs during brain death, when undergoing ischemic damage and rejection. However, intentionally induced, it ameliorates pathological processes like ischemia reperfusion injury, allograft, xenograft or islet rejection, facilitates donor specific tolerance and alleviates chronic allograft changes. We herein consistently summarize the huge amount of data on HO-1 and transplantation that have been generated in multiple laboratories during the last 15years and suggest possible clinical implications and applications for the near future.
血红素加氧酶-1(HO-1)是血红素分解代谢的限速酶,可将血红素转化为 Fe++、一氧化碳和胆绿素。HO-1 在许多病理条件下具有抗炎和调节细胞凋亡的作用。在移植中,HO-1 在脑死亡期间、发生缺血损伤和排斥反应时在器官中过度表达。然而,在诱导时,它可以改善缺血再灌注损伤、同种异体移植物、异种移植物或胰岛排斥等病理过程,促进供体特异性耐受,并减轻慢性移植物改变。我们在此一致总结了过去 15 年来多个实验室在 HO-1 和移植方面产生的大量数据,并提出了其在不久的将来可能的临床意义和应用。